About the Company
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological Research
Employees
67000
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IQV News
IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly
The image below, which you can click on for greater detail, shows that at December 2023 IQVIA Holdings had debt of US$13.7b, ...
Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now
IQVIA Holdings IQV stock has gained 7.5%, outperforming 2.5% and 6.1% growth of the industry it belongs to and the Zacks S&P ...
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching
Good news, investors! IQVIA Holdings is still a bargain right now. According to our valuation, the intrinsic value for the ...
IQVIA (IQV) Appreciates 24% in a Year: Here's What to Know
IQVIA Holdings Inc.’s IQV shares have had an impressive run over the past year. The stock has gained 24.4%, significantly ...
IQVIA Holdings Inc IQV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bank of America Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
Bank of America Securities analyst Michael Ryskin maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today. The ...
Agree To Purchase IQVIA Holdings At $250, Earn 9% Annualized Using Options
Investors eyeing a purchase of IQVIA Holdings Inc (Symbol: IQV) shares, but cautious about paying the going market price of $254.75/share, might benefit from considering selling puts among the ...
Iqvia Holdings (NYSE: IQV)
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments ...
IQVIA (IQV) Gains From Global IT Framework, Liquidity Low
IQVIA Holdings Inc. IQV has had an impressive run over the past six months. The stock has gained 21.7%, outperforming the 13.6% rally of the industry it belongs to and the 12.7% rise of the Zacks ...
Loading the latest forecasts...